Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications - PubMed (original) (raw)

Review

. 2014 Nov;15(11):1009-16.

doi: 10.1038/ni.3002.

Affiliations

Review

Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications

Ying Wang et al. Nat Immunol. 2014 Nov.

Abstract

Mesenchymal stem cells (MSCs) are multipotent stromal cells that exist in many tissues and are capable of differentiating into several different cell types. Exogenously administered MSCs migrate to damaged tissue sites, where they participate in tissue repair. Their communication with the inflammatory microenvironment is an essential part of this process. In recent years, much has been learned about the cellular and molecular mechanisms of the interaction between MSCs and various participants in inflammation. Depending on their type and intensity, inflammatory stimuli confer on MSCs the ability to suppress the immune response in some cases or to enhance it in others. Here we review the current findings on the immunoregulatory plasticity of MSCs in disease pathogenesis and therapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell Biol Int. 2009 Jul;33(7):772-7 - PubMed
    1. Cell Death Differ. 2014 Mar;21(3):388-96 - PubMed
    1. Cancer Res. 2014 Mar 1;74(5):1576-87 - PubMed
    1. Cell Stem Cell. 2012 May 4;10(5):544-55 - PubMed
    1. Blood. 2008 Feb 1;111(3):1327-33 - PubMed

Publication types

MeSH terms

LinkOut - more resources